James A McCormick
Overview
Explore the profile of James A McCormick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
2025
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
McCormick J, Topf J, Tomacruz I, Grimm P
Adv Kidney Dis Health
. 2023 Mar;
30(2):137-147.
PMID: 36868729
Potassium channels are expressed in virtually all cell types, and their activity is the dominant determinant of cellular membrane potential. As such, potassium flux is a key regulator of many...
12.
Maeoka Y, Cornelius R, McCormick J
Hypertension
. 2023 Mar;
80(5):912-923.
PMID: 36861484
The study of rare monogenic forms of hypertension has led to the elucidation of important physiological pathways controlling blood pressure. Mutations in several genes cause familial hyperkalemic hypertension (also known...
13.
Maeoka Y, Cornelius R, Ferdaus M, Sharma A, Nguyen L, McCormick J
Am J Physiol Renal Physiol
. 2022 Aug;
323(5):F564-F576.
PMID: 36007890
Mutations in the ubiquitin ligase scaffold protein cullin 3 (CUL3) cause the disease familial hyperkalemic hypertension (FHHt). We recently reported that in the kidney, aberrant mutant CUL3 (CUL3-Δ9) activity lowers...
14.
Stockand J, Mironova E, Xiang H, Soares A, Contreras J, McCormick J, et al.
Am J Physiol Renal Physiol
. 2022 Jul;
323(4):F468-F478.
PMID: 35900342
The renin-angiotensin-aldosterone and arginine vasopressin-V2 receptor-aquaporin-2 (AQP2) systems converge on the epithelial Na channel (ENaC) to regulate blood pressure and plasma tonicity. Although it is established that V2 receptors initiate...
15.
Maeoka Y, Su X, Wang W, Duan X, Sharma A, Li N, et al.
Hypertension
. 2022 May;
79(7):1423-1434.
PMID: 35506380
Background: MR (mineralocorticoid receptor) antagonists are recommended for patients with resistant hypertension even when circulating aldosterone levels are not high. Although aldosterone activates MR to increase epithelial sodium channel (ENaC)...
16.
Curry J, McCormick J
J Am Soc Nephrol
. 2022 Feb;
33(2):255-256.
PMID: 35101994
No abstract available.
17.
Maeoka Y, Ferdaus M, Cornelius R, Sharma A, Su X, Miller L, et al.
J Am Soc Nephrol
. 2022 Jan;
33(3):584-600.
PMID: 35064051
Background: Mutations in the ubiquitin ligase scaffold protein Cullin 3 () gene cause the disease familial hyperkalemic hypertension (FHHt). In the kidney, mutant () increases abundance of With-No-Lysine (K) Kinase...
18.
Murali S, Little R, Poulsen S, Ferdaus M, Ellison D, McCormick J, et al.
Cells
. 2022 Jan;
11(1).
PMID: 35011657
The thiazide-sensitive sodium chloride cotransporter (NCC) plays a vital role in maintaining sodium (Na) and potassium (K) homeostasis. NCC activity is modulated by with-no-lysine kinases 1 and 4 (WNK1 and...
19.
Matsushita K, Mori K, Saritas T, Eiwaz M, Funahashi Y, Nickerson M, et al.
J Am Soc Nephrol
. 2021 Aug;
32(10):2579-2594.
PMID: 34341182
Background: Rhabdomyolysis, the destruction of skeletal muscle, is a significant cause of AKI and death in the context of natural disaster and armed conflict. Rhabdomyolysis may also initiate CKD. Development...
20.
Moser S, Sugano Y, Wengi A, Fisi V, Rosenbaek L, Mariniello M, et al.
Acta Physiol (Oxf)
. 2021 Jun;
233(1):e13705.
PMID: 34114742
Aim: The phosphorylation level of the furosemide-sensitive Na -K -2Cl cotransporter (NKCC2) in the thick ascending limb (TAL) is used as a surrogate marker for NKCC2 activation and TAL function....